L-arginine and endothelin receptor antagonist bosentan counteract hemodynamic effects of modified hemoglobin

Shock

Volumn 11, Issue 4, 1999, Pages 283-290

  Fischer, Stefanie R ^a   Traber, Daniel L ^a,b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARGININE; BLOOD SUBSTITUTE; BOSENTAN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; HEMOGLOBIN; MACROGOL DERIVATIVE; NITRIC OXIDE; PYRIDOXALATED HEMOGLOBIN POLYETHYLENE GLYCOL CONJUGATE; PYRIDOXALATED-HEMOGLOBIN-POLYETHYLENE GLYCOL CONJUGATE; SULFONAMIDE;

ANIMAL; ARTICLE; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HEMODYNAMICS; METABOLISM; SEPSIS; SHEEP; VASOCONSTRICTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ARGININE; BLOOD SUBSTITUTES; ENDOTHELIN-1; FEMALE; HEMODYNAMIC PROCESSES; HEMOGLOBINS; NITRIC OXIDE; POLYETHYLENE GLYCOLS; RECEPTORS, ENDOTHELIN; SEPSIS; SHEEP; SULFONAMIDES; VASOCONSTRICTION;

EID: 0033110725     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199904000-00010     Document Type: Article

References (34)

1. Gandhi CR, Berkowitz DE, Watkins WD: Endothelins: Biochemistry and pathophysiologic actions. Anesthesiology 80:892-905, 1994.
2. Kroncke KD, Fehsel K, Kolb-Bachofen V: Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol Chem Hoppe Seyles 376:327-343, 1995.
3. Cocks TM, Malta E, King SJ, Woods RL, Angus JA: Oxyhaemoglobin increases the production of endothelin-1 by endothelial cells in culture. Eur J Pharmacol 196:177-182, 1991.
4. Gulati A, Sharma AC, Singh G: Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit Care Med 24:137-147, 1996.
5. Richard V, Hogie M, Clozel M, Loffler BM, Thuillez C: In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation 91:771-775, 1995.
6. Clozel M, Breu V, Gray GA, et al: Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol ExpTher 270:228-235, 1994.
7. G-monomethyl-L-arginine in conscious rats. Br J Pharmacol 118:352-354, 1996.
8. Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS: A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 122:301-308, 1993.
9. Aranow JS, Wang H, Zhuang J, Fink MP: Effect of human hemoglobin on systemic and regional hemodynamics in a porcine model of endotoxemic shock. Crit Care Med 24:807-814, 1996.
10. Bone HG, Schenarts PJ, Booke M, et al: Oxalated pyridoxalated hemoglobin polyoxethylene conjugate normalizes the hyperdynamic circulation in septic sheep. Crit Care Med 25:1010-1018, 1997.
11. Armstead VE, Perkowski SZ, Woolkalis MJ, Spath JA Jr, Gee MH: An association between lung lymph endothelin concentration and survival during endotoxemia in awake sheep. Shock 4:361-367, 1995.
12. Weitzberg E, Hemsen A, Rudehill A, Modin A, Wanecek M, Lundberg JM: Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock. Br J Pharmacol 118:617-626, 1996.
13. Lundblad R Giercksky KE: Endothelin concentrations in experimental sepsis: Profiles of big endothelin and endothelin 1-21 in lethal peritonitis in rats. Eur J Surg 161:9-16, 1995.
14. Fischer SR, Bone HG, Powell WC, McGuire R, Traber LD, Traber DL: Pyridoxalated hemoglobin polyoxyethylene conjugate (PHP) does not restore hypoxic pulmonary vasoconstriction in ovine sepsis. Crit Care Med 25:1551-1559, 1997.
15. Liu SF, Adcock IM, Old RW, Barnes PJ, Evans TW: Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit Care Med 24:1219-1225, 1996.
16. Wileman, SM, Mann GE, Baydoun AR: Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: Synergistic actions of pro-inflammatory cytokines and bacterial lipopolysaccharide. Br J Pharmacol 116:3243-3250, 1995.
17. Lorente JA, Landin L, Renes E, et al: Role of nitric oxide in the hemodynamic changes of sepsis. Crit Care Med 21:759-767, 1993.
18. Koizumi T, Gupta R, Banerjee M, Newman JH: Changes in pulmonary vascular tone during exercise. Effects of nitric oxide (NO) synthase inhibition. L-arginine infusion, and NO inhalation. J Clin Invest 94:2275-2282, 1994.
19. Allman KG, Stoddart AP, Kennedy MM, Young JD: L-arginine augments nitric oxide production and mesenteric blood flow in ovine endotoxemia. Am J Physiol 271:H1296-H1301, 1996.
20. Curzen NP, Kaddoura S, Griffiths MJ, Evans TW: Endothelin-1 in rat endotoxemia: mRNA expression and vasoreactivity in pulmonary and systemic circulations. Am J Physiol 272:H2353-H2360, 1997.
21. Pannen BH, Bauer M, Zhang JX, Robotham JL, Clemens MG: A time-dependent balance between endothelins and nitric oxide regulating portal resistance after endotoxin. Am J Physiol 271:H1953-H1961, 1996.
22. Wanecek M, Oldner A, Rudehill A, Sollevi A, Alving K, Weitzberg E: Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan. Shock 7:364-370, 1997.
23. Wanecek M, Rudehill A, Hemsen A, Lundberg JM, Weitzberg E: The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock. Crit Care Med 25:848-857, 1997.
24. Sharma AC, Singh G, Gulati A: Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am J Physiol 269:H1379-H1388, 1995.
25. Tai J, Kim HW, Greenburg AG: Endothelin-1 is not involved in hemoglobin associated vasoactivities. Artif Cells Blood Substit Immobil Biotechnol 25:135-140, 1997.
26. Kim HW, Greenburg AG: Ferrrous hemoglobin scavenging of endothelium derived nitric oxide is a principal mechanism for hemoglobin mediated vasoactivities in isolated rat thoracic aorta. Artif Cells Blood Substit Immobil Biotechnol 25:121-133, 1997.
27. Boulanger C, Luscher TF: Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85:587-590, 1990.
28. Filep, JG, Foldes Filep E, Rousseau A, Sirois P, Fournier A: Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat. Br J Pharmacol 110:1213-1221, 1993.
29. Hollenberg SM, Piotrowski MJ, Parrillo JE: Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats. Am J Physiol 272:R969-R974, 1997.
30. Hollenberg SM, Cunnion RE, Zimmerberg J: Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 264:H660-H663, 1993.
31. Kilbourn RG, Joly G, Cashon B, DeAngelo J, Bonaventura J: Cell-free hemoglobin reverses the endotoxin-mediated hyporesponsivity of rat aortic rings to alpha-adrenergic agents. Biochem Biophys Res Commun 199: 155-162, 1994.
32. Pittet JF, Morel DR, Hemsen A, et al: Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 213:261-264, 1991.
33. Hinder F, Booke M, Traber LD, et al: Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically elevated atrial natriuretic peptide. Crit Care Med 24:131-136, 1996.
34. Jourdain M, Brazeal B, Traber LD, Traber DL: Modified hemoglobin improved renal function during sepsis in sheep. Proc Amer Burn Assoc 18:S150, 1997.